[1] |
LIANG Yuyan, JI Fang, PAN Ying, XU Shiyao, YANG Shu, XU Liang.
Analysis and discussion of the common problems found in medical device clinical trials inspection results from 2016 to 2023
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 131-137.
|
[2] |
DU Caiying, QUAN Xianghua, SUN Caihong, YUAN Haidan.
Research progress of dalpiciclib in treatment of breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(6): 715-720.
|
[3] |
PENG Yuanyuan, CHEN Bilian.
Research progress of the effect of TMAO on coronary heart disease and the efficacy of antiplatelet drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 590-595.
|
[4] |
LI Jian, WANG Yuzhu, WANG Jun.
Practice of model-informed drug development in pharmaceutical industry in China
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(5): 596-600.
|
[5] |
CHEN Liming, ZHANG Haiyan, HUANG Fan, ZHAO Wenyan, DING Rui, CAO Cai, FANG Yi.
Investigation and analysis of the current status of clinical research nurses
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 455-459.
|
[6] |
ZHOU Xin, WANG Zhi, DU Wenyu, LIU Zihan, LI Ying, DONG Zhanjun.
Research progress in clinical trials of new drugs and candidate drugs for type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(10): 1185-1193.
|
[7] |
WANG Anjing, WANG Yaya, LIANG Xuan, YAN Yajie, SU Jing, LI Caidong.
Research progress on mechanisms and therapeutic drugs of peroxisome proliferator-activated receptor in treatment of cholestatic liver disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 796-808.
|
[8] |
MA Guangli, ZHANG Jing.
Application of quantitative pharmacology in vaccine research and de-velopment: overview and prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 315-322.
|
[9] |
WANG Zhi, ZHOU Xin, HE Xueru, FU Yuhao, XUN Xuejiao, LI Ying, DONG Zhanjun.
Clinical research progress of palbociclib in treatment of breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 205-213.
|
[10] |
DAI Jiahui, SUN Sijia, XIE Xuefeng.
Quality management and indicator system for clinical trials of medical devices
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(1): 51-58.
|
[11] |
CHEN Jianfang, LOU Donghua.
Design of case report form for oncology clinical trials based on CDASH
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 762-767.
|
[12] |
LIU Xing, LU Xiaoran, WU Ying, YU Haitao, WANG Xiaomin.
Ethical analysis and countermeasures of artificial intelligence application in clinical trials
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 322-327.
|
[13] |
ZHU Lili, ZHU Xiuxiu, WANG Wenjun, ZHANG Hailin, LIN Li.
Clinical trials of inhalation in pediatric population in China
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 178-183.
|
[14] |
LI Shanshan, GU Jingwen, ZHANG Jing, YANG Haijing, LIU Wei, YU Yiqi, ZHANG Wenhong.
Design and evaluation of clinical trials of COVID-19 vaccine and monoclonal neutralizing antibody
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 190-197.
|
[15] |
LU Xiya, LI Yuxing, LI Wenzhi, PENG Yuanyuan, HU Yi, WAN Li, CHEN Bilian.
Analysis of prescribing of antiplatelet drug in patients with coronary heart disease in department of geriatrics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1285-1291.
|